Functional insulin therapy: Patient education and algorithms;Insulinothérapie fonctionnelle: Éducation des patients et algorithmes

Diabetes and Metabolism

Volumn 28, Issue 4 II, 2002, Pages

  Grimm, J J ^a   Berger, W ^a   Ruiz, J ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Diabetic education; Functional insulin therapy; Hypoglycaemia; Intensive insulin treatment; Type 1 diabetes

Indexed keywords

INSULIN; ANTIDIABETIC AGENT;

ALGORITHM; CLINICAL PRACTICE; CONFERENCE PAPER; DAILY LIFE ACTIVITY; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; PATIENT EDUCATION; PEDAGOGICS; ARTICLE;

ALGORITHMS; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PATIENT EDUCATION;

EID: 0036716324     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. The Diabetes Control and Complication Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med, 1993, 329, 977-986.
2. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified treatment on the development of microvascular complication of diabetes mellitus. N Engl J Med, 1993, 329, 304-309.
3. Oberholzer J, Toso L, Ris F, et al. Beta cell replacement for the treatment of diabetes. Ann NY Acad Sci, 2001, 944, 373-387.
4. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes, 1997, 46, 271-286.
5. Berger W, Grimm JJ. Insulinothérapie. Comment gérer au quotidien les variation physiologiques des besoins en insuline? Paris: Masson, 1999, 77 pages.
6. Grimm JJ, Hegar K, Berger W. L'insulinothérapie "fonctionnelle" chez le diabétique de type I. In: Journées de diabétologie 2000, Paris: Flammarion Médecine-Sciences, 2000, 145-154.
7. Hegar KE, Schächinger H, Berger W. Reduktion der schweren Hypoglykämien unter funktionneller Insulinotherapie des Typ 1-Diabetes. Praxis, 2002, 91, 4-7.
8. Howorka K, Pumprla J, Wagner-Nosiska D, Grillmayr H, Schlusche C, Schabmann A. Empowering diabetes out-patients with structured education: Short-term and long-term effects of functional insulin treatment on perceived control over diabetes. J Psychosom Res, 2000, 48, 37-44.
9. Langewitz W, Wössmer B, Iseli J, Berger W. Psychological and metabolic improvement after an outpatient teaching program for functional intensified insulin therapy (FIT). Diabetes Res Clin Pract, 1997, 37, 157-164.
10. Torlone E, Pampanelli S, Lalli C, et al. G. Effects of the short-acting insulin analog (Lys-Pro) on postprandial blood glucose control in IDDM. Diabetes Care, 1996, 19, 945-952.
11. Del Sindaco P, Ciofetta M, Lalli C, et al. Use of the short-acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: importance of appropriate replacement of basal insulin and time-interval injection-meal. Diabet Med, 1998, 15, 592-600.
12. Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA. Less Hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. Diabetes Care, 2000, 23, 639-643.
13. Wizemann E, Renner R, Hepp KD. Prospektive Evaluation einer Standardisierten Basalratverteilung für die CSII bei Typ-1-Diabetes über 6 Monate. Diabetes und Stoffwechsel, 10 (suppl. 1), 2001, 57 (Abstract).